citalopram, fluoxetine, sertraline (anxiety and depression) Drugs metabolised by CYP450 2D6: Codeine (opioid painkiller) Inducers CYP450 2C19: Rifampicin (TB) Carbamazepine (epilepsy, trigeminal neuralgia) Inhibitors CYP450 2C19: Lansoprazole, omeprazole (reflex and heartburn) Drugs metabolised by CYP450 2C19: Warfarin (anticoagulant) Diazepam (sedative, anxiolytic) Phenytoin (epilepsy) Inducers CYP450 2C9: Rifampicin (TB) Carbamazepine (epilepsy, trigeminal neuralgia) Inhibitors CYP450 2C9: Miconazole (antifungal) Fluconazole (antifungal) Drugs metabolised by CYP450 2C9: Warfarin (anticoagulant) Non-steroidal anti-inflammatories Clopidogrel (antiplatelet) Genetical variations Genetic variations can lead to altered CYP450 polymorphisms and so altered metabolism of drugs
Expectations should remain moderate for labral tears
It provides strength and structure to skin, bones, tendons, and ligaments
CGM integration (sensor-augmented pumps) Assign Z79.85 (long-term use of injectable non-insulin antidiabetic drugs) for GLP-1 receptor agonists (semaglutide, liraglutide, dulaglutide) and dual GIP/GLP-1 agonists (tirzepatide)
Side effects: what to expect from the combination The addition of niacinamide to semaglutide does not dramatically change the side effect profile